Germany, others stick with AstraZeneca vaccine as some pause

North State Journal - 07 Oct 2021
BERLIN — Officials in several European countries pushed back Friday against decisions by others to pause use of AstraZeneca's coronavirus vaccine following ...

AstraZeneca's AKT inhibitor Truqap hits main goal of prostate cancer study

FirstWord Pharma - 25 Nov 2024
AstraZeneca's AKT inhibitor Truqap hits main goal of prostate cancer study ...

AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med

Fierce Biotech - 22 Nov 2024
AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med ...

AZ's Truqap delivers phase 3 win in prostate cancer subtype after recent breast cancer miss

FiercePharma - 25 Nov 2024
AZ's Truqap delivers phase 3 win in prostate cancer subtype after recent breast cancer miss ...

AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN?

Yahoo Finance - 25 Nov 2024
AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN? ...

AstraZeneca Names A MSK Leader To Global Cancer Post

Forbes - 25 Nov 2024
AstraZeneca Names A MSK Leader To Global Cancer Post ...

GCAR and AstraZeneca execute agreement to evaluate AZD1390 for glioblastoma

Clinical Trials Arena - 25 Nov 2024
GCAR and AstraZeneca execute agreement to evaluate AZD1390 for glioblastoma ...

FDA panel flags risks as AstraZeneca seeks full Andexxa approval

The Pharma Letter - 22 Nov 2024
FDA panel flags risks as AstraZeneca seeks full Andexxa approval ...

AstraZeneca announces results from CAPItello-281 trial

TipRanks - 25 Nov 2024
AstraZeneca announces results from CAPItello-281 trial ...

10 Most Promising Cancer Stocks According to Hedge Funds

Insider Monkey - 22 Nov 2024
10 Most Promising Cancer Stocks According to Hedge Funds ...

AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments

Reuters.com - 12 Nov 2024
AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments ...

Transforming kidney health and the burden of CKD

AstraZeneca - 21 Nov 2024
Transforming kidney health and the burden of CKD ...

AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug

BioSpace - 22 Nov 2024
AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug ...

AstraZeneca’s Truqap Hits In Prostate Cancer

Citeline News & Insights - 25 Nov 2024
AstraZeneca’s Truqap Hits In Prostate Cancer ...

AIM ImmunoTech Defends Board Against $8M Activist Demand Amid AstraZeneca Partnership | AIM Stock News

StockTitan - 25 Nov 2024
AIM ImmunoTech Defends Board Against $8M Activist Demand Amid AstraZeneca Partnership | AIM Stock News ...

AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising Demand

Yahoo Finance - 23 Nov 2024
AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising Demand ...

Positive CAPItello-281 Phase III trial for AstraZeneca

The Pharma Letter - 25 Nov 2024
Positive CAPItello-281 Phase III trial for AstraZeneca ...

AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN?

Insider Monkey - 25 Nov 2024
AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN? ...

AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US

Business Wire - 20 Nov 2024
AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US ...

Bob T. Li

AstraZeneca - 18 Nov 2024
Bob T. Li ...

AstraZeneca